MedPath
HSA Approval

DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG

SIN15521P

DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG

DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG

August 8, 2018

SEA PHARMA CONSULTANCY PTE LTD

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

SEA PHARMA CONSULTANCY PTE LTD

SEA PHARMA CONSULTANCY PTE LTD

Therapeutic

Prescription Only

Formulation Information

CAPSULE, DELAYED RELEASE

ORAL

Medical Information

N06AX16

venlafaxine

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

Pharmathen S.A.

Pharmathen International S.A.

Active Ingredients

Venlafaxine Hydrochloride 169.71mg eqv Venlafaxine

150mg

Venlafaxine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG - HSA Approval | MedPath